Renal thrombotic microangiopathy induced by interferon-alpha.
Badid
C
C
Service de Nephrology, Hôpital Edouard Herriot, Lyon, France.
McGregor
B
B
Faivre
J M
JM
Guerard
A
A
Juillard
L
L
Fouque
D
D
Laville
M
M
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D007668:Kidney / Q000098:blood supply* / Q000503:physiopathology; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D016491:Peripheral Vascular Diseases / Q000139:chemically induced*; D012079:Renal Circulation
D000970:Antineoplastic Agents; D016898:Interferon-alpha